Multicentre Study of the Learning Curve and Surgical Performance of Cytoreductive Surgery with Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei
Overview
Authors
Affiliations
Background: The learning curves for cytoreductive surgery with intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei (PMP) were explored between international centres/surgeons to identify institutional or other factors that might affect performance.
Methods: Data from patients with PMP treated with the combined procedure across 33 international centres between 1993 and 2012 were analysed retrospectively. A risk-adjusted sequential probability ratio test was conducted after defining the target outcome as early oncological failure (disease progression within 2 years of treatment), an acceptable risk for the target outcome (odds ratio) of 2, and type I/II error rates of 5 per cent. The risk prediction model was elaborated and patients were evaluated sequentially for each centre/surgeon. The learning curve was considered to be overcome and proficiency achieved when the odds ratio for early oncological failure became smaller than 2.
Results: Rates of optimal cytoreduction, severe postoperative morbidity and early oncological failure were 84·4, 25·7 and 29·0 per cent respectively. The median annual centre volume was 17 (range 6-66) peritoneal malignancies. Only eight of the 33 centres and six of 47 surgeons achieved proficiency after a median of 100 (range 78-284) and 96 (86-284) procedures respectively. The most important institutional factor affecting surgical performance was centre volume.
Conclusion: The learning curve is extremely long, so centralization and/or networking of centres is necessary to assure quality of services. One centre for every 10-15 million inhabitants would be ideal.
Appendiceal low-grade pseudomyxoma peritonei recurrence with splenic invasion and parastomal hernia.
Liu Q, Jiao J, Yu G, Guo P, Li C Front Surg. 2024; 11:1484812.
PMID: 39640197 PMC: 11617569. DOI: 10.3389/fsurg.2024.1484812.
ASO Author Reflections: Economics of Experience-Institutional Learning Curve of CRS-HIPEC.
Ciftci Y, Radomski S, Johnson B, Johnston F, Greer J Ann Surg Oncol. 2024; 31(13):8602-8603.
PMID: 39320403 DOI: 10.1245/s10434-024-16093-z.
Triphasic Learning Curve of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Ciftci Y, Radomski S, Johnson B, Johnston F, Greer J Ann Surg Oncol. 2024; 31(12):7987-7997.
PMID: 39230850 DOI: 10.1245/s10434-024-15945-y.
New insights in the management of pseudomyxoma peritonei.
Pastier C, de Hingh I, Goere D J Surg Oncol. 2024; 130(6):1316-1325.
PMID: 39206531 PMC: 11826005. DOI: 10.1002/jso.27842.
Moran B, Samuel M, Lord A Ann Surg Oncol. 2024; 32(1):249-250.
PMID: 39164601 DOI: 10.1245/s10434-024-16044-8.